BILL ANALYSIS Ó SENATE COMMITTEE ON APPROPRIATIONS Senator Ricardo Lara, Chair 2015 - 2016 Regular Session SB 423 (Bates) - Retail nonprescription surplus products: determinations for reuse. ----------------------------------------------------------------- | | | | | | ----------------------------------------------------------------- |--------------------------------+--------------------------------| | | | |Version: July 6, 2015 |Policy Vote: E.Q. 7 - 0 | | | | |--------------------------------+--------------------------------| | | | |Urgency: Yes |Mandate: Yes | | | | |--------------------------------+--------------------------------| | | | |Hearing Date: August 27, 2015 |Consultant: Marie Liu | | | | ----------------------------------------------------------------- *********** ANALYSIS ADDENDUM - SUSPENSE FILE *********** The following information is revised to reflect amendments adopted by the committee on August 27, 2015 Bill Summary: AB 423 would establish a process for the handling and management of retail nonprescription pharmaceutical surplus products. Fiscal Impact: Unknown costs to the Hazardous Waste Control Account (special) for the Department of Toxic Substances Control (DTSC) to "register" specified entities Author Amendments: Clarify the roles of the Department of Public Health and DTSC SB 423 (Bates) Page 1 of ? Specify that a facility that elects to follow the procedures in this bill are not subject to regulation of specified products by the Medical Waste Management Act. -- END --